Intuitive Surgical stock climbs after a strong Q2 beat
Published on 08/17/2026 at 08:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Intuitive Surgical Inc. (US46120E6023) is trading after July 16, 2026 results that showed $2.89 billion in second-quarter revenue and $2.80 in adjusted EPS, both above Wall Street estimates. The latest quote snapshot put ISRG at $394.51, with a market value of $139.37 billion and a 52-week range of $414.30 to $603.88.
Q2 beat stays in view
MarketBeat's stock page shows the shares at $394.51 as of August 14, 2026, with extended trading at $394.86 and a small after-hours gain of 0.09%. TradingKey's quote page puts the same close at $394.51, a market cap of $139.37 billion and a year-to-date decline of 30.34%.
The second-quarter report remains the anchor for the current debate: revenue rose 18.4% from a year earlier to $2.89 billion, and adjusted EPS increased from $1.81 in the prior-year quarter to $2.80. Procedure volume also expanded, with combined da Vinci and Ion procedures up 16% year over year and 468 da Vinci systems and 55 Ion systems placed in the quarter.
Margins and guidance
Gross profit margin improved from 67.9% to 70.0% in the quarter, while non-GAAP net margin was 28.45%. For fiscal 2026, Wall Street models in the result stream point to $8.87 in EPS, a figure that sits above the quarter's current run-rate and gives the stock a valuation lens that still depends on procedure growth.
Intuitive Surgical's latest operating mix still leans heavily on recurring instruments and accessories, which reached $1.73 billion in the quarter and helped support the revenue beat. That mix matters because recurring sales can soften the effect of slower system placements when hospitals delay capital spending.
da Vinci remains central
The da Vinci platform is still the company's signature product line, and the quarter's 468 system placements show that demand did not fade after the prior run-up in the shares. The same report also pointed to global da Vinci procedure growth guidance of 13.5% to 15.5% for 2026, which keeps usage growth at the center of the investment case.
For now, the stock's setup is defined by a sharp gap between the August 14, 2026 close at $394.51 and the 52-week high of $603.88. That gap leaves valuation and execution sensitive to every update on procedures, placements and margin discipline.
More on da Vinci
da Vinci is Intuitive Surgical's flagship robotic surgery system, used across minimally invasive procedures and supported by recurring instruments, accessories and service revenue.
Intuitive Surgical shares
As of August 14, 2026, Intuitive Surgical shares closed at $394.51, with extended trading at $394.86 and a market cap of $139.37 billion.
Fact box
Company: Intuitive Surgical Inc.
ISIN: US46120E6023
Ticker: ISRG
Exchange: NASDAQ
Price (as of August 14, 2026, 4:00 p.m. ET): $394.51 USD
Market cap: $139.37 billion (as of August 14, 2026)
Sector / Industry: Health Care / Medical Devices
Index membership: Nasdaq-100
